Cargando…
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
BACKGROUND: The identification of new serum biomarkers with high sensitivity and specificity is an important priority in pancreatic cancer research. Through an extensive proteomics analysis of pancreatic cancer cell lines and pancreatic juice, we previously generated a list of candidate pancreatic c...
Autores principales: | Makawita, Shalini, Dimitromanolakis, Apostolos, Soosaipillai, Antoninus, Soleas, Ireena, Chan, Alison, Gallinger, Steven, Haun, Randy S, Blasutig, Ivan M, Diamandis, Eleftherios P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847832/ https://www.ncbi.nlm.nih.gov/pubmed/24007603 http://dx.doi.org/10.1186/1471-2407-13-404 |
Ejemplares similares
-
Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden
por: Ren, Annie He, et al.
Publicado: (2020) -
Discovery of novel plasma biomarker ratios to discriminate traumatic brain injury
por: Chen, Michelle, et al.
Publicado: (2019) -
A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9
por: Filippou, Panagiota, et al.
Publicado: (2017) -
Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery
por: Prassas, Ioannis, et al.
Publicado: (2012) -
Correction to: A proteome-wide immuno-mass spectrometric identification of serum autoantibodies
por: Music, Milena, et al.
Publicado: (2019)